4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives...

Details 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives... 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives...

2007-01-30

2007-01-30

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S593000

Reexamination Certificate

active

10495494

ABSTRACT:
4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives, which have excellent arginine vasopressin V2activity and are useful for a drug for the treatment of central diabetes insipidus and/or nocturia.

REFERENCES:
patent: 5710150 (1998-01-01), Taniguchi et al.
patent: 5753644 (1998-05-01), Ogawa et al.
patent: 6096736 (2000-08-01), Ogawa et al.
patent: 6340678 (2002-01-01), Matsuhisa et al.
patent: 09-221475 (1997-08-01), None
Kondo et al., Novel Design of Nonpeptide AVP V2 Receptor Agonists: Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepine as a Template, J. of Medicinal Chemistry, Nov. 2000, vol. 43, No. 23, pp. 4388-4397.

Affiliated with

Also associated with

Rating

4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3785426